In primary Sjögren’s syndrome, GBP2 serves as a salivary biomarker that not only distinguishes patients from healthy controls but also differentiates primary Sjögren’s syndrome from systemic lupus erythematosus (121). Here, GBP2 is linked to Sjogren syndrome.